Von Willebrand Disease (VWD) Market

Von Willebrand disease (VWD) is a genetic disorder caused by missing or defective von Willebrand factor (VWF), a clotting protein. VWF binds factor VIII, a key clotting protein, and platelets in blood vessel walls, which help form a platelet plug during the clotting process. Von Willebrand disease is a heterogeneous disorder and is usually classified into two main types, according to inheritance or acquired forms.

It is observed that emales are affected more as compared to males, in the case of Von Willebrand disease (VWD) in the 7MM. The highest diagnosed prevalence of VWD is estimated in the United States, with 11,336 diagnosed cases in 2017.
According to DelveInsight analysis, the total diagnosed prevalent population of VWD in seven major markets was 33,758 in 2017.

For more information on Von Willebrand disease (VWD) Market, visit: https://www.delveinsight.com/report-store/von-willebrand-disease-vwd-market